← Back to RAPP Overview
Rapport Therapeutics, Inc. Common Stock (RAPP)
Price-to-Earnings Ratio History
P/E Ratio (TTM)
-10.55
Financial Fundamentals
RAPP • Quarterly Data • 5Y View
Quarterly P/E
| Quarter | P/E Ratio |
|---|---|
| 2023-03-31 | -16.46 |
| 2023-06-30 | -16.32 |
| 2023-09-30 | -11.40 |
| 2023-12-31 | -6.95 |
| 2024-03-31 | -4.46 |
| 2024-06-30 | -7.06 |
| 2024-09-30 | -5.60 |
| 2024-12-31 | -4.28 |
| 2025-03-31 | -2.01 |
| 2025-06-30 | -3.77 |
| 2025-09-30 | -10.46 |
| 2025-12-31 | -10.55 |
* P/E ratios are calculated using trailing twelve-month (TTM) earnings.